Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
23:00:02 27/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 380.99 USD | +2.30% |
|
+7.47% | +25.74% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 10,179 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 23.96% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,430 | 9,214 | 9,073 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 19.76% | -2.29% | -1.53% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 45.8x | 44.8x | 45.1x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.7x | 19.62x | -63.97x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.96x | 3.88x | 3.83x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.67x | 3.51x | 3.42x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 23.8x | 22.5x | 21x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 32.3x | 29.2x | 27.1x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 30x | 31.2x | 27.4x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.33% | 3.2% | 3.65% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,624 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 395.8 | 408.8 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 292 | 315.4 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 380.99 | 380.99 | 380.99 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 A | 2/16/23 A | 2/15/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 45.79x | 3.67x | 23.82x | - | 10.18B | ||
| 34.11x | 4.04x | 15.18x | 2.52% | 178B | ||
| 23.4x | 4.6x | 16.03x | 1.19% | 116B | ||
| 20.08x | 3.49x | 12.5x | 3.02% | 115B | ||
| 31.91x | 3.07x | 12.4x | 2.23% | 93.1B | ||
| 17.84x | 0.21x | 12.94x | 0.73% | 62.09B | ||
| 31.75x | 7.96x | 20.45x | 1.24% | 55.87B | ||
| 38.68x | 3.58x | 12.18x | 2.14% | 53.12B | ||
| 38.02x | 9.44x | 26.4x | -.--% | 44.22B | ||
| 40.3x | 3.26x | 12.16x | 0.53% | 33.59B | ||
| Average | 32.19x | 4.33x | 16.41x | 1.51% | 76.12B | |
| Weighted average by Cap. | 29.57x | 4.14x | 15.19x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















